| BC | Breast cancer |
| mBC | Metastatic breast cancer |
| TNBC | Triple-negative breast cancer |
| CBDCA | Carboplatin |
| CDDP | Cisplatin |
| SLC31A1 | High Affinity Copper Uptake Protein 1 |
| ATP7B | Copper-Transporting P-type Adenosine Triphosphate |
| ICL | Inter-DNA cross-link |
| SSB | Single-strand break |
| DSB | Double-strand break |
| HR | Homologous recombination repair |
| BER | Base excision repair |
| HRD | Homologous recombination deficiency |
| NHEJ | Non-homologous end joining |
| BRCA1 | Breast Cancer Type 1 Susceptibility Protein |
| BRCA2 | Breast Cancer Type 2 Susceptibility Protein |
| ORR | Objective response rate |
| OS | Overall survival |
| PFS | Progression-free survival |
| PARP | Poly(ADP-ribose) polymerase |
| pCR | Pathologic complete response |
| EFS | Event-free survival |
| DFS | Disease-free survival |
| RCB | Residual cancer burden |
| NPM1 | Nucleophosmin |
| OGG1 | 8-Oxoguanine DNA glycosylase |
| UNG | Uracil-DNA-glyucosylase |
| Polβ | Polymerase β |
| ROS | Reactive oxygen species |
| 8oxoG | Oxidized guanine |
| EFI | Event-free survival |